NeoChord is now training 20 US centers in preparation for a US randomized clinical trial to support a PMA for its NeoChord DS1000 artificial chordae delivery system for minimally invasive mitral valve repair.
The NeoChord DS1000 is a tool for the transapical delivery of expanded polytetrafluoroethylene sutures to replace damaged chordae tendinae –...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?